Effect of Rosiglitazone on Overweight Subjects With Type 1 Diabetes

OBJECTIVE:--To evaluate the safety and effectiveness of rosiglitazone in the treatment of overweight subjects with type 1 diabetes. RESEARCH DESIGN AND METHODS--A total of 50 adult type 1 diabetic subjects with a baseline BMI [>/=]27 kg/m² were randomly assigned in a double-blind fashion to take...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2005-07, Vol.28 (7), p.1562-1567
Hauptverfasser:	Strowig, Suzanne M, Raskin, Philip
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Blood Glucose - metabolism blood pressure Body Mass Index Body Size C-Peptide - blood cholesterol Diabetes Diabetes Mellitus, Type 1 - complications Diabetes Mellitus, Type 1 - drug therapy Diabetes. Impaired glucose tolerance dose response Double-Blind Method Drug therapy Endocrine pancreas. Apud cells (diseases) Endocrinopathies Ethnic Groups Etiopathogenesis. Screening. Investigations. Target tissue resistance Female Glycated Hemoglobin A - analysis glycemic control Humans hypoglycemia Hypoglycemic agents Hypoglycemic Agents - therapeutic use insulin Insulin - therapeutic use insulin resistance insulin-dependent diabetes mellitus Male Medical sciences Metabolic diseases Metabolism Obesity Obesity - complications Obesity - drug therapy overweight Overweight persons Placebos Prescription drugs Rosiglitazone Rosiglitazone maleate Side effects Thiazolidinediones - therapeutic use Type 1 diabetes Weight Gain
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!